ABBOTT LABORATORIES T.ABT

Primary Symbol: ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

NYSE:ABT - Post by User

ABBOTT LABORATORIES > Any news?

<< Previous

Bullboard Posts

Next >>

Comment by NLMooseon Mar 19, 2022 9:59am

176 Views

Post# 34527660

RE:Any news?

Number one reason is that Absolute Software is mismanaged.

While Absolute Software's sales continue to increase, they are still losing money due to excessive spending and mismanagement.

If Absolute Software was well managed, they would make a profit as opposed to incurring losses each quarter.

I think that Absolute Software's Board of Directors, including Christy Wyatt, Daniel Ryan, Lynn Atchison, Andre Mintz, Gregory Monahan, Sal Visca, and Gerhard Watzinger need to be recalled to address concerns about the company's financial management.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023